Annals
Established in 1927 by the American College of Physicians
Search Annals:
Advanced search
 

 Article
   Table of Contents                
   PDF of this article
   Figures/Tables List
 Services
   Notify a friend about this article
   Alert me when this article is cited
   Submit comment on this article
   Download to Citation Manager
   ACP Search
 PubMed
Articles in PubMed by Author:
   Combes, A.
   Théron, D.
   Related Articles in PubMed
   PubMed Citation
   PubMed

LETTER

Conduction Disturbances Associated with Venlafaxine

Alain Combes, MD; Gilles Peytavin, MD; and David Théron, MD

16 January 2001 | Volume 134 Issue 2 | Pages 166-167


TO THE EDITOR:

Venlafaxine is a new antidepressant drug that inhibits serotonin and norepinephrine reuptake. In clinical trials, venlafaxine was found to be safe and effective (1). However, substantial changes in vital signs (hypertension and hypotension) (2) and cardiac rhythm abnormalities (3) have been observed in a few patients, notably the elderly. We describe a case of venlafaxine-associated conduction disturbances that were reversed after administration of sodium bicarbonate.

A 44-year-old woman took an overdose of venlafaxine (3 g), clonazepam (20 mg), lormetazepam (24 mg), and thioridazine (10 mg). She was intubated and admitted to our medical intensive care unit. Gastric lavage was performed and activated charcoal was administered. The initial electrocardiograph tracing showed a sinus rhythm and incomplete right bundle-branch block (Figure on page 167, top). Two hours later, isotonic saline and norepinephrine were infused because of marked vasoparalysis. Ten hours after admission, a second electrocardiogram (Figure, middle) showed atrial fibrillation with wide QRS complexes. Within 15 minute of infusion of 100 mL of 1 M of sodium bicarbonate, a sinus rhythm with narrow QRS complexes was obtained (Figure, bottom). No further rhythm or conduction abnormality was noted over the following days.



View larger version (22K):
[in this window]
[in a new window]
 
Figure. Electrocardiography (ECG) tracings in a patient with venlafaxine toxicity. Top. ECG tracing upon intensive care unit admission showing a sinus rhythm with an incomplete right bundle-branch block. Middle. Ten hours later, the ECG showed atrial fibrillation and wide QRS complex tachycardia. Bottom. The ECG tracing recorded 15 minutes after infusion of 100 mL of 1 M of sodium bicarbonate shows the return to sinus rhythm with narrow QRS complexes.

 

A recent report demonstrated that venlafaxine blocks the fast inward sodium current in a concentration-dependent manner in isolated guinea pig ventricular myocytes, thereby promoting membrane-stabilizing effects (4). Our observations support this experimental result and confirm the in vivo efficacy of sodium bicarbonate in reversing the membrane-stabilizing activity of venlafaxine.

Physicians who prescribe antidepressant drugs should be aware of the potential risk associated with venlafaxine, which shares many of the known toxic effects of tricyclic agents. We strongly recommend prolonged surveillance in an intensive care unit for this type of poisoning and the use of alkalinizing agents to treat severe cardiac conduction disturbances.


Author and Article Information
Top
Author & Article Info
References

Hôpital Bichat; 75877 Paris Cedex 18, France (Combes, Peytavin, Théron)


References
Top
Author & Article Info
References

1. Rudolph RL, Derivan AT. The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database. J Clin Psychopharmacol. 1996;16:54S-59S; discussion 59S-61S. [PMID: 0008784648].

2. Feighner JP. Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry. 1995;56:574-9[PMID: 0008530334].[Medline]

3. Peano C, Leikin JB, Hanashiro PK. Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med. 1997;30:704-8[PMID: 0009360588].[Medline]

4. Khalifa M, Daleau P, Turgeon AJ. Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther. 1999;291:280-4[PMID: 0010490914].[Abstract/Free Full Text]

About Letters

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should: •Include no more than 300 words of text, three authors, and five references •Type with double-spacing •Send three copies of the letter, an authors' form (see Table of Contents for location) signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters. The Internet address is http://www.acponline.org/shell-cgi/letter-article.pl.




 Article
   Table of Contents                
   PDF of this article
   Figures/Tables List
 Services
   Notify a friend about this article
   Alert me when this article is cited
   Submit comment on this article
   Download to Citation Manager
   ACP Search
 PubMed
Articles in PubMed by Author:
   Combes, A.
   Théron, D.
   Related Articles in PubMed
   PubMed Citation
   PubMed


 Home | Current Issue | Past Issues | Search | Collections | PDA Services | Subscribe | Contact Us | Help | ACP Online 

Copyright © 2001 by the American College of Physicians.